$63.52 arrow  Change: 0.38 %Chge: 0.60% Vol: 368,971
End Of Day Prices
High: 63.65 | Low: 62.88 | Open: 62.93 | Close: 63.52
52 Wk High: 66.07 | 52 Wk Low: 46.27 | Todays Pivot: 63.35
Sector: Healthcare and Pharmaceuticals add stock to watch list

BMY Chart

You need Flash Player to see the chart, please download from the link below

Get Adobe Flash player

Related Healthcare and Pharmaceuticals Companies

Gilead Sciences 93.83 red arrow 962,146
Amerisourcebergen 73.3 green arrow 86,904
Charles Riv Labs Intl 38.875 green arrow 21,388
Boston Scientific 20.775 green arrow 419,446
Endo Pharmaceuticals Hldgs 8.465 red arrow 194,329
Johnson & Johnson 108.99 red arrow 283,079
Unitedhealth Group 40.93 red arrow 7,767,300
Unitedhealth Group 57.2 green arrow 365,855

Above is a small selection of related companies to Bristol Myers Squibb which compete alongside BMY within the Healthcare and Pharmaceuticals sector. To see more related companies to BMY, view our stock market today information page.

Online News For Bristol Myers Squibb

Sizzling Stock Alert: Bristol-Myers Squibb Company (BMY)

DACA allows undocumented immigrants brought to America as children to register with the government and remain in the country. But yesterday evening, I restated my position that these negotiations can't last forever, ' McConnell said on the floor.

Bristol-Myers (BMY) Reports Data from CheckMate-142 Study

Bristol-Myers Squibb Company BMY announced new data from a cohort of the phase II CheckMate -142 study on Opdivo. CheckMate-142 study is an ongoing study evaluating Opdivo (nivolumab) and Yervoy (ipilimumab) for previously treated patients with DNA ...

Noteworthy Tuesday Option Activity: BMY, ALGN, IVAC

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Bristol-Myers Squibb Co. (Symbol: BMY), where a total of 28,886 contracts have traded so far, representing approximately 2.9 million underlying shares.

Bristol-Myers Squibb (BMY) Given Sell Rating at BMO Capital Markets

Generally, Wray has sought to avoid the drama and personal confrontations that sometimes flare up inside the Trump administration. He's since countered Trump's denial of Russia's electoral interference and criticized the president publicly .

The Top Three Holders Of Bristol-Myers Squibb Company (BMY)

Shares in US hemophilia specialist Bioverativ (BIVV.O) soared 63 percent after French healthcare group Sanofi (SASY.PA) agreed to buy the company for $11.6 billion. The company has a market cap of $90.64 billion, a PE ratio of 20.19 and a beta of 1.17.

Want To Add This Quote To Your Site?

With our stock widgets you can add a Bristol Myers Squibb quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for BMY to choose from. Visit here to build your stock quote widget »